Wedica 100 MG is for people with type 2 diabetes who aren’t getting good results with metformin, the usual first treatment. It contains Trelagliptin, which was first launched in Japan and is made in Bangladesh. Doctors often switch patients from a daily DPP-4 inhibitor to Wedica in their treatment plan.
Wedica 100 Mg (Trelagliptin) – 16 Tablets
$ 120.00
Wedica 100 Mg (Trelagliptin) which has been carefully developed by Beacon Pharmaceuticals Ltd. and is supplied by Unit Pharmacy, marks a substantial progress in the control of type 2 diabetes. The active ingredient, Trelagliptin Succinate, offers a convenient once-weekly dosing regimen, improving patient adherence and glycemic control.
Wedica 100 Mg works by:
- Inhibiting the DPP-4 enzyme, which increases the levels of incretin hormones.
- Enhancing insulin secretion and reducing glucagon levels in response to meals.
- Improving glycemic control by promoting better glucose homeostasis.
This targeted approach aids in maintaining stable blood sugar levels and reducing HbA1c levels.
Product Feature:
| Manufacturer | : Beacon Pharmaceuticals Ltd. |
| Indication | : Type 2 diabetes mellitus. |
| Generic | : Trelagliptin |
| Formulation | : Tablet |
| Pack Size | : 16 Tablets |
| Strengths | : 100 Mg |
| Storage | : Below 30°C |
Essential medications for Type 2 diabetes mellitus, such as Wedica 100 Mg (Trelagliptin), can be procured from Unit Pharmacy!
Reviews
There are no reviews yet.